
An AFP investigation reveals that Indian pharmaceutical firms are exporting large quantities of high-strength tapentadol tablets to West Africa, fueling a deadly opioid crisis. These potent synthetic opioids, unapproved for general use, are being mixed into the addictive 'zombie drug' kush, causing widespread fatalities in countries like Sierra Leone and Liberia. Despite India's 2025 crackdown banning certain tapentadol combinations, exports of pure tapentadol continue, raising concerns among health officials and prompting national emergencies in the region.
The articles present perspectives from investigative sources, Indian regulatory authorities, and West African health officials, focusing on the export practices of Indian pharmaceutical firms and their impact. Coverage includes government responses such as India's crackdown and regulatory actions, as well as the humanitarian concerns raised by affected countries. The framing is factual, highlighting both regulatory efforts and ongoing challenges without partisan bias.
The overall tone is serious and concerned, reflecting the humanitarian crisis caused by opioid misuse in West Africa. While the articles emphasize the dangers and fatalities linked to tapentadol exports, they also note regulatory measures taken by Indian authorities. The sentiment is predominantly cautionary and critical of ongoing risks, balanced by acknowledgment of official responses.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| news18 | This 'Painkiller' From India Is Fuelling A Deadly 'Zombie Drug' Epidemic In West Africa | Center | Negative |
| economictimes | Indian pharma firms flood west Africa with powerful opioids despite crackdown: AFP investigation | Left | Negative |
economictimes broke this story on 14 May, 03:19 am. Other outlets followed.
Story is receiving appropriate media attention relative to public interest.
TBN's analysis identified the following accountability dimensions in this story.
This story involves alleged misuse of official authority or institutional position to achieve personal or political ends.
This story points to a failure in institutional processes — regulation, safety, oversight, or service delivery breaking down at scale.
This story involves a risk to public safety — infrastructure failure, regulatory lapse, hazardous conditions, or emergency mishandling.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.